JAZZ PHARMS INC

Active trials

• phase3Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancerrecruitingn=286
• phase1A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participantsnot yet recruitingn=188
• phase1A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815active not recruitingn=98
• phase3A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancersactive not recruitingn=920
• phase4Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solutionactive not recruitingn=154
• —Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEAnot yet recruitingn=300
• phase3A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHrecruitingn=120
• phase3A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEEnot yet recruitingn=120